| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $310.8M | +19.5% |
| Cost of Revenue | $64.1M | +21.1% |
| Gross Profit | $246.8M | +19.1% |
| R&D Expense | $32.1M | +2.6% |
| SG&A Expense | $56.7M | -0.4% |
| Operating Income | -$21.7M | +46.5% |
| Pre-tax Income | -$20.2M | +49.6% |
| Income Tax | $59K | +103.4% |
| Net Income | -$20.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.6M | +21.3% |
| Accounts Receivable | $2.4M | -31.7% |
| Current Assets | $56.7M | -0.4% |
| Total Assets | $167.2M | -2.3% |
| Current Liabilities | $62.4M | +1.4% |
| Long-term Debt | $14.3M | -21.3% |
| Total Liabilities | $108.1M | -6.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $10.5M | +59.1% |
| Financing Cash Flow | -$397K | +91.0% |
| +73.7% |
| EPS (Basic) | -$0.17 | +75.4% |
| EPS (Diluted) | -$0.17 | +75.4% |
| Stockholders' Equity |
| $59.2M |
| +5.1% |